Book a meeting - Syngene International Ltd

SOT 62nd Annual Meeting and ToxExpo

Visit us at Booth # 517

About Event

The SOT is a much-awaited event bringing together toxicologists and those working in related areas to share the latest science and technology in the field. It is a great place to network and gain new knowledge/perspectives, including finding a Toxicology partner who best meets your requirements.

Global CRO/CDMO Syngene offers comprehensive Safety Assessment services for small molecules and biologics.

Syngene offerings for Safety Tox Studies

GLP Safety-Tox Studies: Acute repeat dose tox and chronic tox, in vitro tox genotoxicity, safety pharmacology, juvenile tox, DART, IND-enabling
Standalone histopathology services, including peer review by ACVP, spectral insights for digital pathology
Analytical and bioanalytical support for Tox
Online data capture and SEND submission tool
Target dossiers, pharmacogenomics, in silico safety, polypharmacology, MOA
AAALAC-accredited ISO 17025 & GLP-certified animal facility
Talented scientific pool with seven DABTs and one ACVP pathologist

Please share your work details to book a meeting with Syngene during SOT 62nd Annual Meeting and ToxExpo

All fields are mandatory

About Syngene

Syngene International Ltd is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene’s more than 5200 scientists offer both skills and the capacity to deliver great science, robust data management and IP security, and quality manufacturing at speed to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science, including multinationals such as GSK, Zoetis, and Merck KGaA.